BioPharma Dive July 26, 2021
Pratap Khedkar and Jude Konzelmann

Healthcare is an ever-evolving industry, but the pandemic brought new urgency to a few large-scale changes. With a deep understanding of the forces behind these changes, biopharma companies can seek out new ways to collaborate...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma, Pharma / Biotech
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Bariatric Surgeons Being Put Out of Work by GLP-1 Drugs
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025

Share This Article